This study extracted radiomic features from tumor regions and brown adipose tissue regions, analyzed their correlation with TP53 mutation status, and evaluated the distribution differences of these features among three major gynecological tumors—endometrial cancer, cervical cancer, and ovarian cancer. Here, TP53 is linked to cervical cancer.